# A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus

> clinical trial · VERIFIED · 2026-06-29

Status: RECRUITING · Sponsor: ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. · Condition: Systemic Lupus Erythematosus

- Company: ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
- Sector: immunology
- Primary source: https://clinicaltrials.gov/study/NCT06535412

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.